Medpace Holdings, Inc.

MEDP
$557.60 (+ $14.03 + 2.58%)
Last updated: 2026-07-04 14:22 UTC
MEDP Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryDiagnostics & Research
ISINUS58506Q1094
CUSIP58506Q109
Market Price557.6
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio39.99
EPS14.3
Market Cap$16.1B
Book Value10.27
Price to Book55.693
Beta1.43
52w High626.25
52w Low250.05
Next Earnings DateN/A

Medpace Holdings, Inc. trades under ticker MEDP on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US58506Q1094, CUSIP 58506Q109.

About the Company
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Price History